This statistic displays revenue losses of leading pharmaceutical products due to patent expiries in the U.S. from 2014 to 2016. Otsuka's Abilify's U.S. patent will expire in April 2015 and its revenue is expected to drop from almost *** billion U.S. dollars in 2014 down to *** million U.S. dollars in 2016.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Vantage. (December 22, 2014). Revenue losses of leading pharmaceutical products due to patent expiries in the U.S. from 2014 to 2016 (in million U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved August 01, 2026, from /statistics/407976/projected-revenues-of-top-us-pharmaceutical-patent-expiries/
Vantage. "Revenue losses of leading pharmaceutical products due to patent expiries in the U.S. from 2014 to 2016 (in million U.S. dollars)." Chart. December 22, 2014. ÌÇÐÄÆƽâ°æ. Accessed August 01, 2026. /statistics/407976/projected-revenues-of-top-us-pharmaceutical-patent-expiries/
Vantage. (2014). Revenue losses of leading pharmaceutical products due to patent expiries in the U.S. from 2014 to 2016 (in million U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: August 01, 2026. /statistics/407976/projected-revenues-of-top-us-pharmaceutical-patent-expiries/
Vantage. "Revenue Losses of Leading Pharmaceutical Products Due to Patent Expiries in The U.S. from 2014 to 2016 (in Million U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 22 Dec 2014, /statistics/407976/projected-revenues-of-top-us-pharmaceutical-patent-expiries/
Vantage, Revenue losses of leading pharmaceutical products due to patent expiries in the U.S. from 2014 to 2016 (in million U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/407976/projected-revenues-of-top-us-pharmaceutical-patent-expiries/ (last visited August 01, 2026)
Revenue losses of leading pharmaceutical products due to patent expiries in the U.S. from 2014 to 2016 (in million U.S. dollars) [Graph], Vantage, December 22, 2014. [Online]. Available: /statistics/407976/projected-revenues-of-top-us-pharmaceutical-patent-expiries/
